icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
qpRNzg8NB6a3e4HB
Listen
